When was Med fusion founded?

Med fusion was founded in 2010 and raised its 1st funding round 2 years after it was founded.

Where is Med fusion located?

Med fusion is headquartered in Lewisville, United States.

How many employees does Med fusion have?

As of Mar 31, 2026, the latest employee count at Med fusion is 82.

Is Med fusion a funded company?

Med fusion is a funded company, having raised a total of $61.2M across 2 funding rounds to date. The company's 1st funding round was a $***** Conventional Debt round, raised on Mar 2012.

When was the latest funding round of Med fusion?

Med fusion's latest funding was a $***** Series B round on Jan 16, 2014, with participation from 4 investors.

Where does Med fusion rank among its competitors?

Med fusion ranks 185th amongst 726 active competitors, of which 223 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Guardant Health, which secured $350M in Nov, 2025.

Who are the top competitors of Med fusion?

Med fusion's top competitors include Guardant Health, Natera and Human Longevity. Among them, Guardant Health secured the most recent funding round in November, 2025.

Med fusion - 2026 Company Profile, Team, Funding & Competitors

Med fusion is an acquired company based in Lewisville (United States), founded in 2010. It operates as a Precision medicine solutions, advanced diagnostics, and clinical trial support. Med fusion has raised $61.2M in funding from investors like McKesson, Texas Oncology and Pathologist. The company has 726 active competitors, including 223 funded and 171 that have exited. Its top competitors include companies like Guardant Health, Natera and Human Longevity.

Company Details

Precision medicine solutions, advanced diagnostics, and clinical trial support, delivering comprehensive services to healthcare providers and biotech/pharmaceutical companies. It offers advanced laboratory diagnostics, including test development, validation, and reference lab services like pathology and molecular diagnostics. The company focuses on providing tools and services to improve lab efficiency and patient care, offering solutions for hospitals, health systems, employers, and life sciences organizations. It supports clinical trials globally with a comprehensive test menu and assay development. The company empowers better health through diagnostic insights, working with community health centers and ACOs to improve healthcare quality and outcomes. It offers a test directory with detailed information and resources for various tests, catering to specialties like cancer, genetics, neurology, and women's health.

Key Metrics

Founded Year

2010

Location

Lewisville, United States

Stage

Acquired

Total Funding

$61.2M in 2 rounds

Latest Funding Round

Series B, Jan 16, 2014, $*****

Investors

McKesson & 4 more

Ranked

185^th among 726 active competitors

Employee Count

82 as on Mar 31, 2026

Similar Companies

Guardant Health & 981 more

Exit Details

Acquired by Quest Diagnostics (Jun 12, 2017)

View Med fusion's full profile

Med fusion is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
MED FUSION, LLC CIN: 270720545 , United States, Active	Dec 31, 1999	-	-	-

Med fusion got acquired by Quest Diagnostics on Jun 12, 2017.

Click here to take a look at Med fusion's acquisition in detail

Med fusion has raised a total funding of $61.2M over 2 rounds. Its first funding round was on Mar 2012. Its latest funding round was a Series B round on Jan 16, 2014 for $*****. 4 investors participated in its latest round. Med fusion has 5 institutional investors.

Here is the list of recent funding rounds of Med fusion:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 16, 2014	8708229	Series B	7759469	1240335	8663302	9941107
Mar 2012	9818699	Conventional Debt	6662196	7877648	2605633	5672095

Access funding benchmarks and valuations. Sign up today!

View details of Med fusion's funding rounds and investors

Med fusion's employee count trend

Med fusion has 82 employees as of Mar 26. Here is Med fusion's employee count trend over the years:

Uncover Med fusion's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Med fusion include Guardant Health, Natera and Human Longevity. Here is the list of Top 10 competitors of Med fusion, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Guardant Health 2012, Redwood City (United States), Public	Developer of digital sequencing technology for cancer detection	$557M	SoftBank Vision Fund, Orbimed & 24 others	79/100
2nd	Natera 2004, Redwood City (United States), Public	Developer of cell-free DNA testing for oncology, women’s health, and organ health	$152M	Harmony Partners, Harmony Venture Partners ... & 17 others	77/100
3rd	Human Longevity 2013, San Diego (United States), Series B	Provider of precision medicine, preventative health assessments, and longevity care	$409M	Celgene, General Electric & 20 others	76/100
4th	Myriad Genetics 1991, United States, Public	Developer of molecular diagnostics and personalized medicine for cancer	-	Grayhawk Capital, TriplePoint Capital & 6 others	76/100
5th	Juno Therapeutics 2013, Seattle (United States), Acquired	Global biopharmaceutical company discovering, developing, and delivering innovative medicines	$317M	BB Biotech, Bezos Expeditions & 14 others	74/100
6th	Caris Life Sciences 1996, Irving (United States), Public	Developer of panomic disease profiling technologies for cancer precision medicine	$1.23B	Sixth Street, Coatue & 19 others	74/100
7th	Exact Sciences 1995, Madison (United States), Public	Provider of non-invasive molecular diagnostic testing solutions for cancer	-	Petrillo Capital, Bank of America & 8 others	73/100
8th	Foundation Medicine 2010, Cambridge (United States), Acquired	Provider of genomics-based diagnostics test for cancer	$96.5M	Deerfield, Redmile Group & 11 others	71/100
9th	UniQure 1998, Amsterdam (Netherlands), Public	Developer of gene-based therapies for patients with genetic or acquired diseases	$111M	Advent Life Sciences, 4Bio Capital & 11 others	70/100
10th	Prenetics 2009, Hong Kong (China), Public	Online platform for genetic and diagnostic health testing that helps identify health risks	$67.6M	Beyond Ventures, Ping An Ventures & 21 others	70/100
185th	Med fusion 2010, Lewisville (United States), Acquired	Precision medicine solutions, advanced diagnostics, and clinical trial support	$61.2M	McKesson, Texas Oncology & 3 others	45/100